C
PRCT icon

Covestor’s Procept Biorobotics PRCT Stock Holding History

Covestor’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
31
+11
+55% +$275 ﹤0.01% 2295
2026
Q1 		$1K Buy
20
+18
+900% +$507 ﹤0.01% 2122
2025
Q4 		$0 Hold
2
– – ﹤0.01% 2638
2025
Q3 		$0 Hold
2
– – ﹤0.01% 2656
2025
Q2 		$0 Sell
2
-1
-33% -$57 ﹤0.01% 2635
2025
Q1 		$0 Sell
3
-85
-97% -$5.8K ﹤0.01% 2615
2024
Q4 		$7K Buy
88
+10
+13% +$854 ﹤0.01% 1674
2024
Q3 		$6K Buy
78
+74
+1,850% +$5.26K ﹤0.01% 1718
2024
Q2 		$0 Hold
4
– – ﹤0.01% 2634
2024
Q1 		$0 Hold
4
– – ﹤0.01% 2621
2023
Q4 		$0 Hold
4
– – ﹤0.01% 2582
2023
Q3 		$0 Sell
4
-1
-20% -$34 ﹤0.01% 2574
2023
Q2 		$0 Hold
5
– – ﹤0.01% 2524
2023
Q1 		$0 Hold
5
– – ﹤0.01% 2449
2022
Q4 		$0 Hold
5
– – ﹤0.01% 2474
2022
Q3 		$0 Sell
5
-1
-17% -$40 ﹤0.01% 2443
2022
Q2 		$0 Buy
+6
New +$218 ﹤0.01% 2256

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Covestor's PRCT Position: Q2 2026 in Review

Covestor increased its Procept Biorobotics (PRCT) stake by 55% in Q2 2026, buying an estimated $275 and bringing the position to 31 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Covestor first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $7K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Covestor held 31 shares of Procept Biorobotics worth $1K as of Q2 2026.
  • Covestor bought 11 Procept Biorobotics shares in Q2 2026, an estimated $275.
  • Procept Biorobotics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2295 holding.
  • Covestor first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
  • Covestor's Procept Biorobotics position peaked at $7K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.